Solid Biosciences Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Solid Biosciences Stock Summary

Solid Biosciences competes with Century Therapeutics, Edgewise Therapeutics, C4 Therapeutics, Mineralys Therapeutics,, and Cullinan Oncology. Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts. Solid Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 104 people.

Solid Biosciences Key Financial Ratios

Solid Biosciences Key Balance Sheet Accounts

Solid Biosciences Key Income Statement Accounts

Solid Biosciences Key Cash Accounts

Solid Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Solid Biosciences's current stock value. Our valuation model uses many indicators to compare Solid Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Solid Biosciences competition to find correlations between indicators driving Solid Biosciences's intrinsic value. More Info.Solid Biosciences LLC is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Solid Biosciences' Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Solid Biosciences' earnings, one of the primary drivers of an investment's value.

Solid Biosciences LLC Systematic Risk

Today, most investors in Solid Biosciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Solid Biosciences' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Solid Biosciences growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Solid Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Solid Biosciences LLC. We use our internally-developed statistical techniques to arrive at the intrinsic value of Solid Biosciences LLC based on widely used predictive technical indicators. In general, we focus on analyzing Solid Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Solid Biosciences's daily price indicators and compare them against related drivers.

When running Solid Biosciences' price analysis, check to measure Solid Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Solid Biosciences is operating at the current time. Most of Solid Biosciences' value examination focuses on studying past and present price action to predict the probability of Solid Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Solid Biosciences' price. Additionally, you may evaluate how the addition of Solid Biosciences to your portfolios can decrease your overall portfolio volatility.